Department of General Surgery, Medical Faculty of Mersin University, Mersin, Turkey.
Surgery. 2012 Jan;151(1):113-7. doi: 10.1016/j.surg.2011.07.015. Epub 2011 Oct 6.
The present study was designed to evaluate the results of phenolization for pilonidal sinus disease and the risk factors for treatment failure.
Between June 2005 and July 2009, 76 consecutive patients with nonrecurrent sacrococcygeal pilonidal sinus were treated with a phenol treatment and included in the study. The clinical (age, sex, story of treatment for abscess formation, and comorbidity), operative (localization and number of sinus openings and volume of cavity), and follow-up data (healing time, time off work, postoperative complications, morbidity, and number of phenolization sessions) of the patients was recorded. Gender, age, history of abscess drainage, number of sinus openings, localization of sinus openings, volume of cavity, and the number of phenolization sessions were analyzed as risk factors for treatment failure.
The overall success rate was 67% (51 of 76 patients). The mean time to complete healing was 16 days (range, 10-45). The time off work was 0 days. Age and gender were not found to be risk factors for treatment failure (P > .05 and P > .05, respectively). Patients with a history of abscess drainage and more than 3 sinus openings had a significantly higher risk of treatment failure (P = .001 and P = .046, respectively). There was no difference between the localization of sinus openings and treatment failure (P > .05). There were statistically significant differences between treatment failure and both the cavity volume and number of phenolization sessions (P = .016 and P = .001, respectively). Patients were followed up for a mean period of 25 months (range, 13-48). One patient (2%) showed recurrence.
With an early return to work and low rates of complications and recurrence, phenolization is a simple outpatient procedure for the treatment of pilonidal sinus disease in selected patients.
本研究旨在评估苯酚治疗藏毛窦疾病的结果和治疗失败的风险因素。
2005 年 6 月至 2009 年 7 月，对 76 例非复发性尾骶部藏毛窦患者采用苯酚治疗，并将其纳入研究。记录患者的临床（年龄、性别、脓肿形成史和合并症）、手术（定位和窦口数量以及腔体积）和随访数据（愈合时间、休假时间、术后并发症、发病率和苯酚治疗次数）。分析性别、年龄、脓肿引流史、窦口数量、窦口定位、腔体积和苯酚治疗次数作为治疗失败的风险因素。
总成功率为 67%（51/76 例）。完全愈合的平均时间为 16 天（范围为 10-45 天）。休假时间为 0 天。年龄和性别均不是治疗失败的风险因素（P＞0.05 和 P＞0.05）。有脓肿引流史和多于 3 个窦口的患者治疗失败的风险显著增加（P=0.001 和 P=0.046）。窦口定位与治疗失败之间无差异（P＞0.05）。腔体积和苯酚治疗次数与治疗失败之间存在显著差异（P=0.016 和 P=0.001）。患者平均随访 25 个月（范围为 13-48 个月）。1 例（2%）患者复发。
苯酚治疗藏毛窦疾病可早期恢复工作，并发症和复发率低，是一种简单的门诊手术，适用于选择的患者。
